Clinical features associated with the homozygous Trp64Arg mutation of the β3-adrenergic receptor: No evidence for its association with obesity in Japanese

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 6, 1998, Pages 941-946

  Sun, Liming ^a   Ishibashi, Shun ^a   Osuga, Jun Ichi ^a   Harada, Kenji ^a   Ohashi, Ken ^a   Gotoda, Takanari ^a   Fukuo, Yoshihiro ^a,b   Yazaki, Yoshio ^a   Yamada, Nobuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Nippon University School of Medicine   (Japan)

Author keywords

Cholesterol; Diabetes; Hypertension; Obesity; 3 adrenergic receptor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; GENE MUTATION; HUMAN; HYPERTENSION; JAPAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL;

EID: 0031744446     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.6.941     Document Type: Article

References (25)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
2. Bouchard C, Pérusse L. Genetics and obesity. Annu Rev Nutr. 1993;13:337-354.
3. Spiegelman BM, Flier JS. Adipogenesis and obesity. Cell. 1996;87:377-389.
4. Emorine L, Marullo S, Briend-Sutren G, Paety G, Tate K, Delavier-Klutchko C, Strosberg D. Molecular characterization of the human β3-adrenergic receptor. Science. 1989;245:1118-1121.
5. Muzzin P, Revelli J-P, Kuhne F, Gocayne JD, McCombie WR, Venter JC, Giacobino J-P, Fraser CM. An adipose tissue-specific β-adrenergic receptor: molecular cloning and downregulation in obesity. J Biol Chem. 1991;266:24053-24058.
6. Krief S, Lönnqvist F, Raimbault S, Baude B, Spronsen AV, Arner P, Strosberg AD, Ricquier D, Emorine LJ. Tissue distribution of β3-adrenergic receptor in man. J Clin Invest. 1993;91:344-349.
7. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional β3-adrenoceptor in the human heart. J Clin Invest. 1996;98:556-562.
8. Benseid M, Kaghad M, Rodriguez M, Le Fur G, Caput D. The rat β3-adrenergic receptor gene contains an intron. FEBS Lett. 1993;318:223-226.
9. Suslic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper M-E, Himms-Hagen J, Flier JS, Lowell BB. Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem. 1995;270:29483-29492.
10. Clément K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 1995;333:52-54.
11. Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 1995;333:348-351.
12. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg D, Stem MP, Raben N, Sorkin JD, Roth J, Shuldiner AR. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med. 1995;33:343-347.
13. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K, Walston J, Yoshinaga H, Kosaka K, Yamada N, Saito Y, Hagura R, Akanuma Y, Shuldiner A, Yazaki Y, Kadowaki T. A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 1995;215:555-560.
14. Yoshida T, Sakane N, Umekawa T, Sakai M, Takahashi T, Kondo M. Mutation of β3 adrenergic receptor gene and response to treatment of obesity. Lancet. 1995;346:1433-1434.
15. 64 Arg mutation of the β3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 1996;39:349-352.
16. Sakane N, Yoshida T, Umekawa T, Kondo M, Sakai Y, Takahashi T. β3-Adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia. 1997;40:200-204.
17. Kim-Motoyama H, Yasuda K, Yamaguchi T, Yamada N, Katakura T, Shuldiner AR, Akanuma Y, Ohashi Y, Yazaki Y, Kadowaki T. A mutation of the β3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 1997;40:469-472.
18. Higashi K, Ishikawa T, Ito T, Yonemura A, Shige H, Nakamura H. Association of a genetic variation in the β3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun. 1997;232:728-730.
19. Urhammer SA, Clausen JO, Hansen T, Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the β3-adrenergic receptor gene. Diabetes. 1996;45:1115-1120.
20. 64 Arg mutation is overrepresented in obese women. Diabetes. 1996;45:1358-1363.
21. 64 Arg polymorphism in the beta-3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia. 1996;39:857-860.
22. 64 Arg mutation in the β3 adrenergic receptor gene has no effects on obesity phenotypes in the Québec family study and Swedish obese subjects cohorts. J Clin Invest. 1996;98:2086-2093.
23. Silver K, Walston J, Wang Y, Dowse G, Zimmet P, Shuldiner AR. Molecular scanning for mutations in the β3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1996;81:4155-4158.
24. 64 Arg mutation in the β3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab. 1997;82:1284-1287.
25. 64Arg missense mutation of the β3-adrenergic receptor gene in Japanese subjects. Metabolism. 1997;46:199-202.